CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Grant or award Pres&Chief Investment Officer acquired 18,836,547 shares (grant or award)
- 4 Grant or award President & COO acquired 204,000 shares (grant or award)
- 4 Shares withheld for taxes CFO gave up 2,341 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 10,945 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 958 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 215 shares (to pay taxes)
- 4 Grant or award Director acquired 1,555 shares (grant or award)
- 4 Grant or award Director acquired 1,702 shares (grant or award)
- 4 Shares withheld for taxes CFO gave up 2,340 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 2,129 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 3,087 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 10,945 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 2,341 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 16,003 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,363 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 2,340 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 83 shares (to pay taxes)
Page 12 of 26 · 511 filings